|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02666 UNI MEDICAL
Nominal 
4.650 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 4,993,965 | 2,032,068 | (1,400,570) | (971,721) |
| Net Cash from / (used in) Investing Activities | -- | (1,058,997) | (121,398) | (664,522) | (296,531) |
| Net Cash from / (used in) Financing Activities | -- | (3,793,636) | (1,576,418) | 2,391,778 | (34,628) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 141,332 | 334,252 | 326,686 | (1,302,880) |
| Cash & Cash Equivalents at beginning of period | -- | 2,705,342 | 2,396,338 | 2,036,535 | 3,385,867 |
| Effect of Foreign Exchange Rate Changes | -- | 2,299 | (25,248) | (21,143) | (46,452) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,848,973 | 2,705,342 | 2,342,078 | 2,036,535 |
| Remarks: | Real time quote last updated: 25/11/2024 08:41 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,137,235 |
| %Change | 3.662% |
| EPS / (LPS) | RMB 0.600 |
| NBV Per Share (¥) | RMB 8.940 |